ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "synovial fluid"

  • Abstract Number: 2156 • 2016 ACR/ARHP Annual Meeting

    IL-6 and TNF-α Modulate Expressions of Cell Cycle Regulators of Rheumatoid Arthritis Fibroblast-like Synoviocytes

    Kenta Kaneshiro1, Teppei Hashimoto2, Kohsuke Yoshida1, Ayako Nakai1, Naonori Hashimoto1, Kohjin Suzuki1, Koto Uchida1, Yoshiko Kawasaki2, Natsuko Nakagawa3, Nao Shibanuma4, Yoshitada Sakai5 and Akira Hashiramoto6, 1Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Department of Rheumatology, Kobe Kaisei Hospital, Kobe, Japan, 3Department of Orthopaedic Surgery, Konan-Kakogawa Hospital, Kakogawa, Japan, 4Departmant of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 5Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 6Department of Biophysics, Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan

    Background/Purpose:   Iinterleukin(IL)-6 and tumor necrosis factor(TNF)-α play important roles in the pathogenesis of RA, however, it remains unclear how they affect or modulate the…
  • Abstract Number: 2561 • 2016 ACR/ARHP Annual Meeting

    A Novel Pharmacological Action of MTX on RA Fibroblast-like Synoviocytes Via Circadian Clock Genes

    Kohjin Suzuki1, Kohsuke Yoshida1, Teppei Hashimoto2, Kenta Kaneshiro1, Ayako Nakai1, Naonori Hashimoto1, Yoshiko Kawasaki2, Nao Shibanuma3, Natsuko Nakagawa4, Yoshitada Sakai5 and Akira Hashiramoto6, 1Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Department of Rheumatology, Kobe Kaisei Hospital, Kobe, Japan, 3Departmant of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 4Department of Orthopaedic Surgery, Konan-Kakogawa Hospital, Kakogawa, Japan, 5Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 6Department of Biophysics, Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan

    Background/Purpose: The circadian rhythm is disrupted in patients with rheumatoid arthritis (RA), and we have shown that tumor necrosis factor(TNF)-ƒ¿ inhibits the expression of circadian…
  • Abstract Number: 3216 • 2016 ACR/ARHP Annual Meeting

    Integrated High-Dimensional Analyses Reveal a Pathologically Expanded ‘Peripheral’ B Cell-Helper T Cell Population in Rheumatoid Arthritis

    Deepak Rao1, Michael Gurish2, Kamil Slowikowski3, Chamith Fonseka2, Jennifer Marshall4, Yanyan Liu5, Laura T. Donlin6, Lauren Henderson7, Fumitaka Mizoguchi8, Nikola Teslovich9, Michael Weinblatt10, Elena Massarotti10, Jonathan Coblyn11, Simon M. Helfgott10, Yvonne C. Lee12, Derrick J. Todd10, Vivian P. Bykerk13, Susan M. Goodman14, Alessandra B. Pernis15, Lionel Ivashkiv14, Elizabeth W. Karlson10, Peter Nigrovic9, Andrew Filer16, Christopher Buckley17, James Lederer18, Soumya Raychaudhuri19 and Michael Brenner1, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Rheumatology, Immunology, Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Divisions of Rheumatology and Genetics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 6Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 7Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 8Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 9Brigham and Women's Hospital and Harvard Medical School, Cambridge, MA, 10Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 11Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 12Rheumatology Immunology & Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 13Divison of Rheumatology, Hospital for Special Surgery, New York, NY, 14Medicine, Hospital for Special Surgery, New York, NY, 15David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 16University of Birmingham, Birmingham, United Kingdom, 17Rheumatology, University of Birmingham, Birmingham, United Kingdom, 18Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 19Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Determining the pathologic functions of T cells that infiltrate target tissues remains a central challenge in autoimmune diseases. In rheumatoid arthritis (RA), the formation…
  • Abstract Number: 3218 • 2016 ACR/ARHP Annual Meeting

    Synovial Mast Cells Associate with High Disease Activity and Predict Radiographic Progression at 12 Months in Patients with Early Rheumatoid Arthritis

    Felice Rivellese1, Frances Humby1, Stephen Kelly1, Amato de Paulis2, Gianni Marone2 and Costantino Pitzalis1, 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 2Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy

    Background/Purpose:   Mast cells (MCs) are immune cells present in the synovial membrane and implicated in the pathogenesis of Rheumatoid Arthritis, although their exact contribution…
  • Abstract Number: 310 • 2016 ACR/ARHP Annual Meeting

    A Novel One Stage Technique Applicable during Arthroscopy for the Mobilization of Synovial Mesenchymal Stromal Cells Towards Joint Regeneration

    Alam Khalil-Khan1, Thomas Baboolal2, Elena Jones3, Owen Wall4 and Dennis McGonagle3, 1Faculty of Medicine, Leeds institute of Rheumatic and Musculoskeletal Medicine,, Leeds, United Kingdom, 2PhD, Leeds, United Kingdom, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 4Orthopaedic Surgery, Department of Trauma and Orthopaedics, Leeds, United Kingdom

    Background/Purpose: , The discovery of MSCs in the synovium and synovial fluid (SF) provided a potential mechanism for repairing cartilage “from the top down”. Indeed,…
  • Abstract Number: 380 • 2016 ACR/ARHP Annual Meeting

    Linear Discriminant Analysis of Cultured Fibroblast-like Synoviocytes Identifies 6 Candidate Genes Which Predict Extended Course in Juvenile Idiopathic Arthritis

    AnneMarie Brescia1, Megan Simonds2, Suzanne McCahan3, Tim Bunnell3, Kathleen E. Sullivan4 and Carlos D. Rosé1, 1Pediatric Rheumatology, Thomas Jefferson University/ AI duPont Hospital for Children, Wilmington, DE, 2Nemours, Nemours Biomedical Research, Wilmington, DE, 3Nemours Biomedical Research, Wilmington, DE, 4Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: The goal of this project is the identification of informative synovial biomarkers to predict which children with oligoarticular juvenile idiopathic arthritis (JIA) will have…
  • Abstract Number: 1093 • 2016 ACR/ARHP Annual Meeting

    DNA Methylation Defines Joint Specific Differences in Synovial Fibroblasts  from OA and RA Patients

    Emmanuel Karouzakis1, Mojca Frank Bertoncelj2, Kerstin Klein1, Christoph Kolling3, Renate E. Gay1, Steffen Gay1 and Caroline Ospelt1, 1Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Schulthess Clinic, Zurich, Switzerland

    Background/Purpose: Recent studies revealed epigenetic changes in DNA methylation associated with rheumatoid arthritis (RA) synovial fibroblasts (SF). In addition, we have shown that SF exhibit…
  • Abstract Number: 1096 • 2016 ACR/ARHP Annual Meeting

    Augmentation of Wnt Signaling By IL-1β in Fibroblast-like Synoviocytes

    Satoshi Yamasaki1, Yusuke Yoshida2 and Eiji Sugiyama2, 1Hiroshima University Hospital, Hiroshima, Japan, 2Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan

    Background/Purpose: Wnt family proteins canonically stabilize β-catenin to activate T-cell factor (TCF) for the transcription of several genes, including Runx2, which is important for osteoblastogenesis.…
  • Abstract Number: 1627 • 2015 ACR/ARHP Annual Meeting

    HIF-1alpha Knockdown Down-Regulates Glycolytic Metabolism and Induces Rheumatoid Synovial Fibroblast Cell Death

    Manuel J. Del Rey1, Alicia Usategui1, Álvaro Valín1, María Sánchez-Aragó2, José M. Cuezva2, Carmen M. García-Herrero1, María Galindo1, Juan D. Cañete3, Francisco J. Blanco4, Gabriel Criado1 and Jose L. Pablos1, 1Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 2Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Investigación Hospital 12 de Octubre, Universidad Autónoma de Madrid, Madrid, Spain, 3Unitat d’Artritis, Servei de Reumatologia, Hospital Clínic de Barcelona and Institut d’Investigacions Biomèdiques August Pí i Sunyer, Barcelona, Spain, 4Laboratorio de Investigación Osteoarticular y del Envejecimiento, Instituto de Investigación Biomédica de A Coruña, INIBIC, A Coruña, Spain

    Background/Purpose: Intense synovial fibroblast (SF) hyperplasia contributes to the chronic inflammation and osteoarticular destruction that characterizes rheumatoid arthritis (RA). Hypoxia-inducible factor 1α (HIF-1α) plays a…
  • Abstract Number: 2133 • 2015 ACR/ARHP Annual Meeting

    Receptor Protein Tyrosine Phosphatase Alpha Enhances Rheumatoid Synovial Fibroblast Signaling and Promotes Arthritis in Mice

    Stephanie M. Stanford1, Mattias N. D. Svensson1, Cristiano Sacchetti1, Caila A. Pilo1, Dennis J. Wu1, William B. Kiosses2, Annelie Hellvard3, Brith Bergum3, German R. Aleman Muench1, Christian Elly1, Yun-Cai Liu1, Jeroen den Hertog4,5, Ari Elson6, Jan Sap7, Piotr Mydel3, David L. Boyle8, Maripat Corr8, Gary S. Firestein8 and Nunzio Bottini1, 1Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 2The Scripps Research Institute, La Jolla, CA, 3Clinical Science, Broegelmann Research Laboratory, Bergen, Norway, 4Hubrecht Institute-Koninklijke Nederlands Akademie van Wetenschappen and University Medical Center Utrecht, Utrecht, Netherlands, 5Institute of Biology Leiden, Leiden, Netherlands, 6Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel, 7Epigenetics and Cell Fate, Université Paris Diderot Sorbonne Paris Cité, Paris, France, 8Division of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, La Jolla, CA

    Background/Purpose: Rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) promote disease pathogenesis by aggressively invading the joint extracellular matrix. The focal adhesion kinase (FAK) signaling pathway is…
  • Abstract Number: 2446 • 2015 ACR/ARHP Annual Meeting

    Synovial Fluid Proteins Differentiate Patients with Oligoarticular Juvenile Idiopathic Arthritis Who Are Destined to Extend from Those Who Will Remain Persistent in Course

    AnneMarie C. Brescia1, Megan M. Simonds2, Kathleen E. Sullivan3 and Carlos D. Rose4, 1Pediatric Rheumatology, Nemours A.I. duPont Hospital for Children, Wilmington, DE, 2Nemours Research, Nemours/AI duPont Hospital for Children, Wilmington, DE, 3Allergy Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA, 4Pediatrics, Nemours A.I. duPont Hospital for Children, Division of Pediatric Rheumatology, Thomas Jefferson University, Wilmington, DE

    Background/Purpose: Children with oligoarticular juvenile idiopathic arthritis (JIA) who have an extended course (recruitment of 5 or more joints after 6 months of disease) have…
  • Abstract Number: 2467 • 2015 ACR/ARHP Annual Meeting

    Interaction Between Senescent T Cells and Fibrocyte-like Cells through CD31, TNFα, and IL-17 Create a Tissue Destructive Environment in the Synovium in Juvenile Idiopathic Arthritis

    Ian D. Ferguson1, Patricia Griffin2, Hiroshi Yano3, Joshua J. Michel2, Jeffrey A. Dvergsten4, Sarah L. Gaffen5, Margalit E. Rosenkranz1, Daniel A. Kietz1 and Abbe N. Vallejo1, 1Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, 2Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, 3Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 4Department of Pediatrics, Duke University Medical Center, Durham, NC, 5Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA

    Background/Purpose: T cells are considered effectors of immunopathology in JIA. In previous work, we reported dominance of senescent CD8T cells in synovial fluid of children…
  • Abstract Number: 2546 • 2015 ACR/ARHP Annual Meeting

    Targeting Synovial Fibroblasts By the Intra-Articular Delivery of microRNA-140-3p and -5p Ameliorates Experimental Autoimmune Arthritis

    Chrong-Reen Wang1, Jia-Shiou Peng2, Shih-Yao Chen3, Chao-Liang Wu4 and Ai-Li Shiau5, 1Rheum/Immun Sec/Int Med Dept, Medical Coll/Nat'l Cheng Kung, Tainan, Taiwan, 2Institute of Basic Medical Sciences, Medical Coll/Nat'l Cheng Kung, Tainan, Taiwan, 3Internal Medicine, Medical Coll/Nat'l Cheng Kung, Tainan, Taiwan, 4Biochemistry and Molecular Biology, Medical Coll/Nat'l Cheng Kung, Tainan, Taiwan, 5Microbiology and Immunology, College of Medicine, National Cheng Kung University, Medical Coll/Nat'l Cheng Kung, Tainan, Taiwan

    Background/Purpose: Synovial fibroblasts (SF) with aberrant expression of microRNAs (miRNA) are critical pathogenic regulators of rheumatoid joint, and studies examining the effect of overexpressing or…
  • Abstract Number: 2569 • 2015 ACR/ARHP Annual Meeting

    Regulation of SIRT1 Maybe a Perfect Strategy in Treatment of Rheumatoid Arthritis

    Sang-Yeob Lee1, Sung Won Lee2, Won Tae Chung2, Jae Ho Bae3, So Youn Park4 and Chi Dae Kim4, 1Division of Rheumatology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea, 2Rheumatology, Dong-A University Hospital, Busan, South Korea, 3Biochemistry, Pusan national university, Yong -San, South Korea, 4Medical Research Center for Ischemic Tissue Regeneration, Pusan national university, Yong -San, South Korea

    Background/Purpose: Monocyte may differentiate to osteoclasts in bone and macrophages in joint. so, blocking of monocyte differentiation maybe effective target in RA (rheumatoid arthritis) treatment.…
  • Abstract Number: 2703 • 2015 ACR/ARHP Annual Meeting

    Reduction in Matrix Metalloproteinase-1 and -2 Secretion from Fibroblast-like Synoviocytes after Induction of Adipogenesis By a Natural Peroxisome Proliferator-Activated Receptor Gamma Ligand, Arterpilin-C

    Eiji Sugiyama1, Satoshi Yamasaki1 and Je-Tae Woo2,3, 1Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan, 2Department of Biological Chemistry, Chubu University, Aichi, Japan, 3JT WOO, Okinawa Research Center Co., Ltd, Okiawa, Japan

    Background/Purpose: Fibroblast-like synoviocytes (FLS) play important roles in rheumatoid arthritis (RA) by producing matrix metalloproteinase (MMP) and cytokines, and hence, these cells are a therapeutic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology